EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Allergic bronchopulmonary aspergillosis in India

Ritesh Agarwal iD, Inderpaul Singh Sehgal, Valliappan Muthu, Raja Dhar, Darius Armstrong-James

Clinical & Experimental Allergy · 2023

DOI: 10.1111/cea.14319 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Experimental Allergy, 2023. Verfasst von Ritesh Agarwal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Aspergillosis, Allergic Bronchopulmonary, Asthma, Cystic Fibrosis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 128 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allergic bronchopulmonary aspergillosis (ABPA) is a lung disorder caused by immune‐mediated reactions mounted against Aspergillus fumigatus . The disorder most commonly complicates the course of patients with asthma and cystic fibrosis. From its first description in 1952, significant advances have been made in understanding the pathogenesis and the diagnosis and treatment of ABPA. In the last two decades, most research on ABPA has been published from India. The prevalence and clinical presentation may differ in India from that reported elsewhere. Herein, we review the epidemiology, clinical and radiological characteristics, and distinctive features of ABPA in the Indian subcontinent. To support the review, we surveyed pulmonologists nationwide to understand the challenges in diagnosing and managing ABPA. The survey has yielded valuable insights into the practices associated with the diagnosis and management of ABPA in India.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aspergillosis, Allergic BronchopulmonaryAsthmaCystic FibrosisHumansAspergillus fumigatusIndia

Stichwörter der Autor:innen

ABPMallergic bronchopulmonary mycosesallergic fungal airway diseaseallergic sensitizationfungal asthmafungal sensitization

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Pulmonology, CK Birla Hospitals, Kolkata, India.
  • Department of Infectious Disease, Faculty of Medicine, Imperial College, London, UK.

ORCID-Profile: Ritesh Agarwal

Zitieren

APA

Agarwal, R., Sehgal, I. S., Muthu, V., Dhar, R., & Armstrong-James, D. (2023). Allergic bronchopulmonary aspergillosis in India. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14319

Vancouver

Agarwal R, Sehgal IS, Muthu V, Dhar R, Armstrong-James D. Allergic bronchopulmonary aspergillosis in India. Clinical & Experimental Allergy. 2023. doi:10.1111/cea.14319

BibTeX
@article{Agarwal2023,
  author = {Agarwal, Ritesh and Sehgal, Inderpaul Singh and Muthu, Valliappan and Dhar, Raja and Armstrong-James, Darius},
  title = {Allergic bronchopulmonary aspergillosis in India},
  journal = {Clinical & Experimental Allergy},
  year = {2023},
  doi = {10.1111/cea.14319}
}
Kostenlos starten →